标题/作者	年份
Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society–USA Panel MS Saag, RT Gandhi, JF Hoy, RJ Landovitz, MA Thompson, PE Sax, ... Jama 324 (16), 1651-1669	2020
Association of HIV preexposure prophylaxis with incidence of sexually transmitted infections among individuals at high risk of HIV infection MW Traeger, VJ Cornelisse, J Asselin, B Price, NJ Roth, J Willcox, BK Tee, ... Jama 321 (14), 1380-1390	2019
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial KH Mayer, JM Molina, MA Thompson, PL Anderson, KC Mounzer, ... The Lancet 396 (10246), 239-254	2020
Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017 T Finlayson, S Cha, M Xia, L Trujillo, D Denson, J Prejean, D Kanny, ... Morbidity and Mortality Weekly Report 68 (27), 597	2019
Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV EPF Chow, AE Grulich, CK Fairley The lancet HIV 6 (6), e396-e405	2019
Technical brief: prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV World Health Organization World Health Organization	2019
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline LE Coelho, TS Torres, VG Veloso, RJ Landovitz, B Grinsztejn The Lancet HIV 6 (11), e788-e799	2019
Global PrEP roll-out: recommendations for programmatic success KR Amico, LG Bekker The lancet HIV 6 (2), e137-e140	2019
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study CA Koss, ED Charlebois, J Ayieko, D Kwarisiima, J Kabami, LB Balzer, ... The lancet HIV 7 (4), e249-e261	2020
Daily and event‐driven pre‐exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence B Vuylsteke, T Reyniers, I De Baetselier, C Nöstlinger, T Crucitti, J Buyze, ... Journal of the International AIDS Society 22 (10), e25407	2019
Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care D Krakower, KM Maloney, VE Powell, K Levine, C Grasso, K Melbourne, ... Journal of the International AIDS Society 22 (2), e25250	2019
Going global: the adoption of the World Health Organization’s enabling recommendation on oral pre-exposure prophylaxis for HIV I Hodges-Mameletzis, S Dalal, B Msimanga-Radebe, M Rodolph, ... Sexual health 15 (6), 489-500	2018
Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019 R Hayes, AJ Schmidt, A Pharris, Y Azad, AE Brown, P Weatherburn, ... Eurosurveillance 24 (41), 1900598	2019
HIV treatment and prevention 2019: current standards of care N Phanuphak, RM Gulick Current Opinion in HIV and AIDS 15 (1), 4-12	2020
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study JM Baeten, T Palanee-Phillips, NM Mgodi, AJ Mayo, DW Szydlo, ... The lancet HIV 8 (2), e87-e95	2021
Drug resistance during HIV pre-exposure prophylaxis KM Gibas, P van den Berg, VE Powell, DS Krakower Drugs 79, 609-619	2019
HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia and factors associated with the nonuse of PrEP among eligible men: results from a prospective cohort study MA Hammoud, S Vaccher, F Jin, A Bourne, L Maher, M Holt, BR Bavinton, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 81 (3), e73-e84	2019
The role of saliva in gonorrhoea and chlamydia transmission to extragenital sites among men who have sex with men: new insights into transmission EPF Chow, CK Fairley Journal of the International AIDS Society 22, e25354	2019
Substantial decline in use of HIV preexposure prophylaxis following introduction of COVID-19 physical distancing restrictions in Australia: results from a prospective observational study of gay and bisexual men MA Hammoud, A Grulich, M Holt, L Maher, D Murphy, F Jin, B Bavinton, ... Journal of acquired immune deficiency syndromes (1999) 86 (1), 22	2021
HIV pre-exposure prophylaxis: scaling up for impact now and in the future BR Bavinton, AE Grulich The Lancet Public Health 6 (7), e528-e533	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。